| Literature DB >> 28430618 |
Manish Adhikari1, Bhawana Negi2, Neha Kaushik3, Anupriya Adhikari4, Abdulaziz A Al-Khedhairy5, Nagendra Kumar Kaushik1, Eun Ha Choi1.
Abstract
Mycotoxins are highly diverse secondary metabolites produced in nature by a wide variety of fungus which causes food contamination, resulting in mycotoxicosis in animals and humans. In particular, trichothecenes mycotoxin produced by genus fusarium is agriculturally more important worldwide due to the potential health hazards they pose. It is mainly metabolized and eliminated after ingestion, yielding more than 20 metabolites with the hydroxy trichothecenes-2 toxin being the major metabolite. Trichothecene is hazardously intoxicating due to their additional potential to be topically absorbed, and their metabolites affect the gastrointestinal tract, skin, kidney, liver, and immune and hematopoietic progenitor cellular systems. Sensitivity to this type of toxin varying from dairy cattle to pigs, with the most sensitive endpoints being neural, reproductive, immunological and hematological effects. The mechanism of action mainly consists of the inhibition of protein synthesis and oxidative damage to cells followed by the disruption of nucleic acid synthesis and ensuing apoptosis. In this review, the possible hazards, historical significance, toxicokinetics, and the genotoxic and cytotoxic effects along with regulatory guidelines and recommendations pertaining to the trichothecene mycotoxin are discussed. Furthermore, various techniques utilized for toxin determination, pathophysiology, prophylaxis and treatment using herbal antioxidant compounds and regulatory guidelines and recommendations are reviewed. The prospects of the trichothecene as potential hazardous agents, decontamination strategies and future perspectives along with plausible therapeutic uses are comprehensively described.Entities:
Keywords: apoptosis; decontamination; herbal antioxidant compounds; oxidative damage; trichothecenes
Mesh:
Substances:
Year: 2017 PMID: 28430618 PMCID: PMC5464924 DOI: 10.18632/oncotarget.15422
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Mycotoxins and its related fungus with contaminating foods
| Mycotoxin | Food Products | Related fungi |
|---|---|---|
| Aflatoxins | Cereals, oil seeds, spices, dry fruits, other nuts and corn | |
| Fumonisins | Mainly in cereals and corns | |
| Ochratoxin | Cereals, legumes, coffee beans | |
| Patulin | Grapes, apples, other fruits | |
| Trichothecenes (T-2/toxins) | Wheat, corn |
Figure 1Schematic representation of T-2 toxin by its toxic and safe design
Figure 2Structures of T-2 and HT-2 toxins (type A) and other trichothecenes (types B, C, and D)
Figure 3Microbial transformation of trichothecenes into their de-epoxylated forms
Relative toxicity of different mycotoxins on different livestock species
| # = Slight toxicity ## = Adequate toxicity ### = High toxicity | |||
|---|---|---|---|
| Toxin | Poultry | Ruminants | Swine |
| Aflatoxins | ### | # | ## |
| T-2 toxins | ## | ### | ### |
| Ochratoxin | ### | # | # |
| Zearalenone | # | ## | ### |
| Fumonisin | # | # | ### |
| Deoxynivalenol | # | ## | ## |
Figure 4Diagrammatic representation of altered metabolic pathways in different organs of Wistar rats followed by T-2 toxin treatment
Metabolites shown in red or blue denote a significant increase or decrease in T-2 toxin treated rats with respect to control rats. Metabolites shown in black denote no marked change. (Reproduced from Wan Q et al. 2015 Mol. Biosyst. with permission of The Royal Society of Chemistry).
LD50 values of T-2 toxin in different animals with different administration pathways
| Species | Mode of administration | LD50 (mg/kg bw) | References |
|---|---|---|---|
| Mice | Oral | 10 | Ueno 1984 |
| Mice | Intraperitoneal | 5.2 | Ueno 1984 |
| Mice | Subcutaneous | 2.1 | Ueno 1984 |
| Mice | Intravenous | 4.2 | Ueno 1984 |
| Rats | Intraperitoneal | 1.5 | Creasia et al. 1990 |
| Rats | Subcutaneous | 1.0 | Bergmann et al. 1985 |
| Rats | Intramuscular | 0.85 | Chan et al. 1984 |
| Rats | Intravenous | 0.9 | Fairhurst et al. 1987 |
| Rats | Inhalation | 0.05 | Creasia et al. 1990 |
| Guinea Pigs | Intraperitoneal | 1.2 | Creasia et al. 1990 |
| Guinea Pigs | Intravenous | 1-2 | Fairhust et al. 1987 |
| Guinea Pigs | Inhalation | 0.4 | Creasia et al. 1990 |
| Rabbits | Intramuscular | 1.1 | Chan et al. 1984 |
| 7-days-old broilers | Oral | 4 | Hoerr et al. 1981 |
| Pigs | Intravenous | 1.21 | Weaver et al. 1978 |
Figure 5The impact of T-2 mycotoxins on the human intestinal gut region against infection by salmonella
(Reproduced from Antonissen et al., 2014, with the permission of the Toxin Journal).
Figure 6Role of the T-2 toxin in causing ROS-mediated caspase-dependent and independent apoptosis in human cells
Estimated daily intakelevels and total T-2 and HT-2 toxins present in cereals and cereal-based products by assuming a body weight of 55 kg
| Samples | Consumption (g/day) | Total Toxins present (μg/kg) | Estimated daily intake [ng/kg bw/day] |
|---|---|---|---|
| Brown Rice | 2.92 | 48.3 | 2.56 |
| Barley | 6.71 | 26.4 | 3.22 |
| Mixed Grains | 4.6 | 30.2 | 2.53 |
| Corn | 0.03 | 63.0 | 0.03 |
| Wheat | 0.02 | 39.8 | 0.01 |
| Wheat flour | 3.95 | 34.1 | 2.45 |
Figure 7Three targeting strategies in a T-2-toxin-based therapy
(Reproduced from Shapira A 2010 with the permission of the Toxin Journal).